SPONSOR
Shandong New Time Pharmaceutical Co., LTD
Total Trials
2
Recruiting
2
Phases
Phase 2, Phase 3
Conditions studied: Relapsed or Refractory Multiple MyelomaRelapsed or Refractory Multiple Myeloma (RRMM)
Shandong New Time Pharmaceutical Co., LTD is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Relapsed or Refractory Multiple Myeloma, Relapsed or Refractory Multiple Myeloma (RRMM).
The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Shandong New Time Pharmaceutical Co., LTD
How many clinical trials has Shandong New Time Pharmaceutical Co., LTD sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Shandong New Time Pharmaceutical Co., LTD, of which 2 are actively recruiting participants. These trials cover conditions including Relapsed or Refractory Multiple Myeloma, Relapsed or Refractory Multiple Myeloma (RRMM). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Shandong New Time Pharmaceutical Co., LTD research focus on?
Shandong New Time Pharmaceutical Co., LTD clinical trials span Relapsed or Refractory Multiple Myeloma, Relapsed or Refractory Multiple Myeloma (RRMM). The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Shandong New Time Pharmaceutical Co., LTD clinical trial?
To participate in a Shandong New Time Pharmaceutical Co., LTD trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shandong New Time Pharmaceutical Co., LTD trials with current recruitment status updated daily.
Clinical Trials by Shandong New Time Pharmaceutical Co., LTD
NCT07312188 Phase 2
Recruiting
A Study of F182112 in the Treatment of Patients With Relapsed or Refractory Multiple Myeloma
Relapsed or Refractory Multiple Myeloma
NCT07579234 Phase 3
Recruiting
A Multicenter, Randomized, Open-label, Parallel-group, Controlled, Superiority Phase III Clinical Study Comparing the Efficacy and Safety of F182112 Versus Standard of Care in Patients With Relapsed or Refractory Multiple Myeloma
Relapsed or Refractory Multiple Myeloma (RRMM)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology